ALGM vs REGN · rev $725.0M vs P/E 14, rev $14.34B
Allegro Microsystems Inc (ALGM) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Allegro Microsystems Inc (ALGM) is a semiconductors company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ALGM revenue for 2025-03-28 was $725.0M. Net income was -$72.8M. Revenue was down 30.9% from 2024-03-29 to 2025-03-28. ALGM currently screens at market cap $9.99B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ALGM currently screens at market cap $9.99B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ALGM and REGN stock pages for the full models.
Not investment advice.